Link to Full Article Cambridge, UK., 7th May 2019: Arecor Limited (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces dosing of the first patient in its Phase I clinical trial for its ultra-rapid acting […]
Link to Full Article Cambridge, UK., 3rd May 2019: Arecor Limited (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology, ArestatTM to develop superior treatments for a range of disease areas, including diabetes, today announces that it has signed a collaboration with a new major global pharmaceutical partner. Under […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-05-03 03:50:152019-05-23 03:53:53ARECOR SIGNS A NEW MULTI-PRODUCT COLLABORATION WITH A MAJOR GLOBAL PHARMACEUTICAL COMPANY
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-04-30 04:00:062019-05-23 04:02:13AVITA Medical Third Quarter Fiscal 2019 Quarterly Cash Flow Report and Company Update
Link to full article A pilot project in the United Kingdom is testing a wrist device that is worn like a watch, called Personal Kinetigraph (PKG), to help Parkinson’s patients and their specialist healthcare providers to monitor their condition at home. The PKG, developed by Global Kinetics, will be tested in the “Developing Home-based Parkinson’s Care” project, […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-04-18 05:18:532019-04-29 05:19:05Pilot Project Tests Wrist Device That Monitors Symptoms at Home
Link to full Article Will Brooks and Jeremy Curnock Cook, 17 April 2019 The healthcare sector has seen huge investment growth and more specialised products starting to emerge. Two specialists navigate what is on offer. Global spending on healthcare is projected to reach $10 trillion by 2022. Venture capital flowing into UK medtech companies has […]
By Charlie Johnson, CEO of ADC Bio, adcbio.com Link to full article The scale of patient demand has fuelled an overarching healthcare market need to expand the drug development pipeline to generate more biologics to treat multiple diseases and innovative new biopharmaceuticals to further enhance the treatment of cancer. The effectiveness of antibody drug conjugates and […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-04-16 04:59:232019-04-26 05:00:49The Evolving Shape of the ADC Market: The Widening Application of ADCs and Manufacturing Improvements Meeting Demand
Link to Full Report Well-funded and on track Brighton, United Kingdom – 9 April 2019 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company focused on the development of novel anti-microbial drugs which address the global problem of anti-microbial resistance (AMR), announces its audited financial results for the year ended 31 December 2018. Financial […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-04-09 05:42:192019-05-23 05:49:43Audited results for the year ended 31 December 2018
Professor Fiona Wood, co-inventor of the RECELL System, described her experience treating more than 3,500 patients using RECELL and resulting benefits including reduced time to healing and decreased length of hospitalization The publication of the RECELL System pivotal trial in the treatment of second-degree burns was selected as a top journal publication for 2018 Link […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-04-08 05:03:352019-08-15 03:57:21AVITA Medical Announces Presentation at ABA Meeting Highlighting Results of Study Using RECELL® System to Treat Third-Degree Burns in Pediatric Patients
London and Oxbridge ‘Golden Triangle’ retains top position, hosting 1 in 3 biotechs The number of UK biotechs has increased by 65% in the last three years, according to analysis by London -based investment management firm Downing LLP. The growth has been fueled by record levels of investment as the UK biotech industry attracted £2.2 […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-04-04 01:53:492019-04-04 01:53:49UK biotech industry surges by 65%, giving hope· as Brexit looms
Link to full article PORTSMOUTH, NH USA, and MELBOURNE, Australia, April 2, 2019 Global Kinetics Pty Ltd., a medical device company focused on the development and commercialization of the first FDA-cleared and CE-marked wearable watch for the objective treatment and management of Parkinson’s disease, called the Personal KinetiGraph® (PKG®), today announced the appointment of Gregory […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2019-04-02 05:11:582019-04-29 05:16:24Global Kinetics Corporation Appoints Greg Barrett As Independent Director to its Board of Directors
ULTRA-RAPID ACTING INSULIN PRODUCT CANDIDATE AT247 FOR DIABETES
/in ArecorLink to Full Article Cambridge, UK., 7th May 2019: Arecor Limited (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces dosing of the first patient in its Phase I clinical trial for its ultra-rapid acting […]
ARECOR SIGNS A NEW MULTI-PRODUCT COLLABORATION WITH A MAJOR GLOBAL PHARMACEUTICAL COMPANY
/in ArecorLink to Full Article Cambridge, UK., 3rd May 2019: Arecor Limited (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology, ArestatTM to develop superior treatments for a range of disease areas, including diabetes, today announces that it has signed a collaboration with a new major global pharmaceutical partner. Under […]
AVITA Medical Third Quarter Fiscal 2019 Quarterly Cash Flow Report and Company Update
/in Avita MedicalThird Quarter Fiscal 2019 Quarterly Cash Flow Report and Company Update
Pilot Project Tests Wrist Device That Monitors Symptoms at Home
/in GKCLink to full article A pilot project in the United Kingdom is testing a wrist device that is worn like a watch, called Personal Kinetigraph (PKG), to help Parkinson’s patients and their specialist healthcare providers to monitor their condition at home. The PKG, developed by Global Kinetics, will be tested in the “Developing Home-based Parkinson’s Care” project, […]
Healthcare Investing: Wealth Managers Chart Way Forward
/in BioSciences ManagersLink to full Article Will Brooks and Jeremy Curnock Cook, 17 April 2019 The healthcare sector has seen huge investment growth and more specialised products starting to emerge. Two specialists navigate what is on offer. Global spending on healthcare is projected to reach $10 trillion by 2022. Venture capital flowing into UK medtech companies has […]
The Evolving Shape of the ADC Market: The Widening Application of ADCs and Manufacturing Improvements Meeting Demand
/in ADC BioBy Charlie Johnson, CEO of ADC Bio, adcbio.com Link to full article The scale of patient demand has fuelled an overarching healthcare market need to expand the drug development pipeline to generate more biologics to treat multiple diseases and innovative new biopharmaceuticals to further enhance the treatment of cancer. The effectiveness of antibody drug conjugates and […]
Audited results for the year ended 31 December 2018
/in Destiny PharmaLink to Full Report Well-funded and on track Brighton, United Kingdom – 9 April 2019 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company focused on the development of novel anti-microbial drugs which address the global problem of anti-microbial resistance (AMR), announces its audited financial results for the year ended 31 December 2018. Financial […]
AVITA Medical Announces Presentation at ABA Meeting Highlighting Results of Study Using RECELL® System to Treat Third-Degree Burns in Pediatric Patients
/in Avita MedicalProfessor Fiona Wood, co-inventor of the RECELL System, described her experience treating more than 3,500 patients using RECELL and resulting benefits including reduced time to healing and decreased length of hospitalization The publication of the RECELL System pivotal trial in the treatment of second-degree burns was selected as a top journal publication for 2018 Link […]
UK biotech industry surges by 65%, giving hope· as Brexit looms
/in BioSciences ManagersLondon and Oxbridge ‘Golden Triangle’ retains top position, hosting 1 in 3 biotechs The number of UK biotechs has increased by 65% in the last three years, according to analysis by London -based investment management firm Downing LLP. The growth has been fueled by record levels of investment as the UK biotech industry attracted £2.2 […]
Global Kinetics Corporation Appoints Greg Barrett As Independent Director to its Board of Directors
/in GKCLink to full article PORTSMOUTH, NH USA, and MELBOURNE, Australia, April 2, 2019 Global Kinetics Pty Ltd., a medical device company focused on the development and commercialization of the first FDA-cleared and CE-marked wearable watch for the objective treatment and management of Parkinson’s disease, called the Personal KinetiGraph® (PKG®), today announced the appointment of Gregory […]